A Typical Preparation of Francisella tularensis O-Antigen Yields a Mixture of Three Types of Saccharides

被引:21
|
作者
Wang, Qi
Shi, Xiaofeng
Leymarie, Nancy
Madico, Guillermo [2 ]
Sharon, Jacqueline [2 ]
Costello, Catherine E.
Zaia, Joseph [1 ]
机构
[1] Boston Univ, Sch Med, Dept Biochem, MS Resource, Boston, MA 02118 USA
[2] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA
基金
美国国家卫生研究院;
关键词
ELECTRON-CAPTURE DISSOCIATION; STRUCTURAL-ANALYSIS; MONOCLONAL-ANTIBODIES; TULAREMIA VACCINES; LIPOPOLYSACCHARIDE; VIRULENCE; LIVE; EPIDEMIOLOGY;
D O I
10.1021/bi201450v
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tularemia is a severe infectious disease in humans caused by the Gram-negative bacterium Francisella tularensis (Ft). Because of its low infectious dose, high mortality rate, and the threat of its large-scale dissemination in weaponized form, development of vaccines and immunotherapeutics against Ft is essential. Ft lipopolysaccharide (LPS), which contains the linear graded-length saccharide component O-antigen (OAg) attached to a core oligosaccharide, has been reported as a protective antigen. Purification of LPS saccharides of defined length and composition is necessary to reveal the epitopes targeted by protective antibodies. In this study, we purified saccharides from LPS preparations from both the Ft subspecies holarctica live vaccine strain (LVS) and the virulent Ft subspecies tularensis SchuS4 strain using liquid chromatography. We then characterized the fractions using high-resolution mass spectrometry and tandem mass spectrometry. Three types of saccharides were observed in both the LVS and SchuS4 preparations: two consisting of OAg tetrasaccharide repeats attached to one of two core oligosaccharide variants and one consisting of tetrasaccharide repeats only (coreless). The coreless OAg oligosaccharides were shown to contain Qui4NFm (4,6-dideoxy-4-formamido-D-glucose) at the nonreducing end and QuiNAc (2-acetamido-2,6-dideoxy-O-D-glucose) at the reducing end. Purified homogeneous preparations of saccharides of each type will allow mapping of protective epitopes in Ft LPS.
引用
收藏
页码:10941 / 10950
页数:10
相关论文
共 50 条
  • [21] Evidence Suggesting That Francisella tularensis O-Antigen Capsule Contains a Lipid A-Like Molecule That Is Structurally Distinct from the More Abundant Free Lipid A
    Barker, Jason H.
    Kaufman, Justin W.
    Apicella, Michael A.
    Weiss, Jerrold P.
    PLOS ONE, 2016, 11 (06):
  • [22] Attenuation and protective efficacy of an O-antigen-deficient mutant of Francisella tularensis LVS
    Li, Jiaxin
    Ryder, Cheryl
    Mandal, Manas
    Ahmed, Farzana
    Azadi, Parastoo
    Snyder, D. Scott
    Pechous, Roger D.
    Zahrt, Thomas
    Inzana, Thomas J.
    MICROBIOLOGY-SGM, 2007, 153 : 3141 - 3153
  • [23] Francisella tularensis blue-gray phase variation involves structural modifications of lipopolysaccharide O-antigen, core and lipid A and affects intramacrophage survival and vaccine efficacy
    Soni, Shilpa
    Ernst, Robert K.
    Muszynski, Artur
    Mohapatra, Nrusingh P.
    Perry, Malcolm B.
    Vinogradov, Evgeny
    Carlson, Russell W.
    Gunn, John S.
    FRONTIERS IN MICROBIOLOGY, 2010, 1
  • [24] Characterisation of the core part of the lipopolysaccharide O-antigen of Francisella novicida (U112)
    Vinogradov, E
    Perry, MB
    CARBOHYDRATE RESEARCH, 2004, 339 (09) : 1643 - 1648
  • [25] EVALUATION OF A SAFRANIN-O-STAINED ANTIGEN MICROAGGLUTINATION TEST FOR FRANCISELLA-TULARENSIS ANTIBODIES
    BROWN, SL
    MCKINNEY, FT
    KLEIN, GC
    JONES, WL
    JOURNAL OF CLINICAL MICROBIOLOGY, 1980, 11 (02) : 146 - 148
  • [26] Glycoconjugate vaccine using a genetically modified O antigen induces protective antibodies to Francisella tularensis
    Stefanetti, Giuseppe
    Okan, Nihal
    Fink, Avner
    Gardner, Erica
    Kasper, Dennis L.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (14) : 7062 - 7070
  • [27] Grey variants of the live vaccine strain of Francisella tularensis lack lipopolysaccharide O-antigen, show reduced ability to survive in macrophages and do not induce protective immunity in mice
    Hartley, G
    Taylor, R
    Prior, J
    Newstead, S
    Hitchen, PG
    Morris, HR
    Dell, A
    Titball, RW
    VACCINE, 2006, 24 (07) : 989 - 996
  • [28] O-ANTIGEN BIOTIN CONJUGATES - PREPARATION AND USE IN DIRECT COMPETITIVE ENZYME IMMUNOASSAYS
    MEIKLE, PJ
    YOUNG, NM
    BUNDLE, DR
    JOURNAL OF IMMUNOLOGICAL METHODS, 1990, 132 (02) : 255 - 261
  • [29] Functional Genomics of the Aeromonas salmonicida Lipopolysaccharide O-Antigen and A-Layer from Typical and Atypical Strains
    Merino, Susana
    de Mendoza, Elena
    Canals, Rocio
    Tomas, Juan M.
    MARINE DRUGS, 2015, 13 (06): : 3791 - 3808
  • [30] Evasion of complement-mediated lysis and complement C3 deposition are regulated by Francisella tularensis lipopolysaccharide O antigen
    Clay, Corey D.
    Soni, Shilpa
    Gunn, John S.
    Schlesinger, Larry S.
    JOURNAL OF IMMUNOLOGY, 2008, 181 (08): : 5568 - 5578